EnglishGermanChinese (Simplified)FrenchJapanese

Lewy Body Dementia Test

Worried about Lewy Body Dementia (LBD)? Explore the groundbreaking SYNTapTest! Identify the biomarker driving LBD early, long before symptoms appear. ➡️

NIH
McGovern-Logo-1
ADDF-Logo-1

What's the Lewy Body Dementia Test?

Named SYNTap™ Biomarker Test, it identifies misfolded Synuclein, the biomarker driving Lewy Body Dementia (LBD). Molecular testing enables doctors to diagnose the disease accurately. Proper drugs can then be confidently prescribed, as the wrong drugs might harm patients more than helping them.

Who should take the LBD Test?

This test benefits people who show:

  1. Early memory disorder symptoms, which could be Alzheimer’s or other brain diseases.
  2. Signs of cognitive decline and autonomic symptoms, including sleep disorders, constipation, heart rate problems, or fainting spells.
  3. Signs of cognitive decline and movement problems, including rigidity, tremors, shuffling, or leaning to one side.

What are the key benefits?

The LBD Test offers remarkable benefits such as:

  • Enables LBD early diagnosis, years before symptoms appear. When the disease is diagnosed early, patients have a better chance to slow or stop the progression through proper treatment as the brain is healthier.

  • Differentiates LBD from Alzheimer’s and other brain diseases, empowering physicians to match the right patient with the right drug.

  • Terminates the turbulent ride of the emotional, financial, and mental drain of uncertainty for the patients and their loved ones.

  • Extinguishes the misery of misdiagnosis, which leads to drug mistreatment causing more harm than help.

  • Live a longer, better quality of life through changes in diet, exercise, and sharing time with family and friends.

  • Participate in the right clinical trials with confidence.

  • Make life plans to navigate brain health journey, such as building a care team.

  • Enrich science to accelerate innovation and find cures for the next generations!

Molecular diagnosis is key to personalized medicine for treating Lewy Body Dementia.

Misdiagnosis is a grim fact for people living with LBD. Conservatively estimated up to 50%!

It’s time to END that now.

Get the LBD Test

Amprion - hero images - 77

Misdiagnosis is a grim fact for LBD patients. Conservatively estimated up to 50%! 

Let’s END that now!

LBD Test Sign Up

How the LBD Test works

After a decade of strenuous development in our lab, it’s quite simple now. Here’re three key steps: 

  1. Your doctor orders the test and submits a few drops of your cerebrospinal fluid (CSF),
  2. Our lab tests your sample for misfolded Synuclein,
  3. Your doctor receives the lab result within two weeks.

Click here to see the simple process illustrated in an infographic.

Watch this short video to take your understanding of microscopic brain proteins to galactic levels. 

Why test CSF instead of blood?

CSF testing offers the highest accuracy, reliability, and EARLY detection. Why?

Because if misfolded proteins are detectable in blood, that means they’ve breached the blood-brain barrier and are spreading throughout the body.

What does a negative LBD Test mean?

A negative SYNTap Test result rules out LBD.  

For those who show symptoms, doctors can now confidently explore other possible causes.

It’s recommended to retake the test in 12-24 months to monitor brain health.

Lewy Body Dementia is the most recently observed brain disease; it only got named 40 years ago!  

Science has been fighting hard, but this disease is densely shrouded in profound mystery.

To defeat the dark force, we need to travel beyond enemy lines to gather intel and formulate our battle plans. Every biomarker test blasts a blazing light, illuminating the shadowy land of LBD.

With ongoing reconnaissance, we empower science to finally find a cure!

Amprion - hero images - 47

Lewy Body Dementia is the most recently observed brain disease; it only got named 40 years ago!  

Science has been fighting hard, but this disease is densely shrouded in profound mystery.

To defeat the dark force, we need to travel beyond enemy lines to gather intel and formulate our battle plans. Every biomarker test blasts a blazing light, illuminating the shadowy land of LBD.

With ongoing reconnaissance, we empower science to finally find a cure!

GET THE SYNTap™ BIOMARKER TEST

This diagnostic test identifies misfolded Synuclein, a prion-protein driving Lewy Body Dementia (LBD), years before symptoms. Thus, it aids physicians in diagnosing LBD. Sign up to receive information about the test. 

Share this life-changing news with someone you love! 💑

amprion logo quote solid blue
Do good by doing well, do well by doing good.
Scroll to Top
Share on facebook
Share on twitter
Share on linkedin
Amprion Icon
Make Every Minute Count. Join the Fight!